INS and metabolic process: After three months treatment, the serum level of AREG was declined nearly 10%, accompanied by decreased BMI, SBP, DBP, FBG, FPI, SUA, TC and HOMA-IR, indicating promising weight loss, improved metabolism disorders and recovered insulin sensitivity.